Common Safety Follow-up Trial of Tecemotide (L-BLP25)
Clinical trial NCT01423760 · TERMINATED
Trial details
- NCT number
- NCT01423760
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2015-07-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.